- Home
- CYRX vs AMRN Comparison
CYRX vs AMRN Comparison
Compare CYRX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | AMRN |
|---|---|---|
| Founded | 1999 | 1989 |
| Country | United States | Ireland |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 339.8M |
| IPO Year | 2008 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CYRX | AMRN |
|---|---|---|
| Price | $7.93 | $14.39 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 9 | 1 |
| Target Price | ★ $12.94 | $12.00 |
| AVG Volume (30 Days) | ★ 425.4K | 61.8K |
| Earning Date | 03-03-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.22 | 55.00 |
| EPS | ★ 1.40 | N/A |
| Revenue | $176,177,000.00 | ★ $181,104,000.00 |
| Revenue This Year | $10.92 | N/A |
| Revenue Next Year | $8.08 | $1.26 |
| P/E Ratio | $5.86 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $4.63 | $0.39 |
| 52 Week High | $11.45 | $20.90 |
Technical Indicators
Market Signals| Indicator | CYRX | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 44.21 |
| Support Level | $6.57 | $13.63 |
| Resistance Level | $8.52 | $14.55 |
| Average True Range (ATR) | 0.39 | 0.72 |
| MACD | 0.05 | -0.08 |
| Stochastic Oscillator | 29.44 | 9.51 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.